Fox Chase Cancer Center’s ACE Program Wins 2025 ACCC Innovator Award
Association of Cancer Care Centers shared a post on LinkedIn:
“Ambulatory oncology settings face a number of external challenges that inhibit the delivery of high-quality patient care, particularly inefficiencies in patient access, clinic workflows, and care coordination.
In this episode, CANCER BUZZ speaks with Anna Liza Rodriguez chief nursing officer and vice president of nursing and patient care services at Fox Chase Cancer Center about her program’s receipt of a 2025 ACCC Innovator Award. Fox Chase Cancer Center’s innovation, Ambulatory Care Excellence (ACE): Charting a New Path in Ambulatory Care Model and Coordination, is a structured approach designed to improve efficiency, coordination, and patient outcomes in ambulatory cancer care while ensuring top of license scope of work for clinicians.
Joel Helmke, Chief Operating Officer at Fox Chase Cancer Center, shared this post on LinkedIn, adding:
“So proud of our leadership team for the progress they are making by standardizing the multidisciplinary care model at FCCC. I have seen these efforts fail at other organizations for a variety of reasons, but our team has persevered and achieved tangible results. Great work that should be shared.”
More posts featuring Association of Cancer Care Centers.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023